NCT03273946View on ClinicalTrials.gov

Post-marketing Safety Monitoring Program of Fluticasone Propionate (FP) in Chinese Subjects With Asthma Aged 1 to <4 Years

CompletedOBSERVATIONAL
Enrollment

158

Participants

Timeline

Start Date

January 9, 2018

Primary Completion Date

September 27, 2018

Study Completion Date

September 27, 2018

Conditions
Asthma
Interventions
DRUG

Fluticasone propionate

Fluticasone propionate is an inhaled corticosteroid to be used via a pediatric spacer device with a face mask for prophylactic treatment of asthma.

Trial Locations (4)

200040

GSK Investigational Site, Shanghai

200092

GSK Investigational Site, Shanghai

200127

GSK Investigational Site, Shanghai

518038

GSK Investigational Site, Shenzhen

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT03273946 - Post-marketing Safety Monitoring Program of Fluticasone Propionate (FP) in Chinese Subjects With Asthma Aged 1 to <4 Years | Biotech Hunter | Biotech Hunter